-
-
Despite dramatic and widely reported breakthroughs in preventing bloodstream infections, the cold truth is that too many infection preventionists labor in obscurity, their programs woefully underfunded by administrators blind to the power of prevention.
-
-
Infection preventionists must seize an extraordinary moment in health care, when divergent forces are aligning to redesign a system that has failed to contain costs and protect the lives to which it has been entrusted, Atul Gawande, MD, MPH, said recently in New Orleans in the keynote address at the 37th annual educational conference of the Association for Professionals in Infection Control and Epidemiology (APIC).
-
Alarming public health officials, a highly drug-resistant gram negative bacterial strain that is emerging rapidly in hospitals in India has been detected in patients in three U.S. states.
-
Hospitals that adopt advanced computer technology to identify healthcare-associated infections (HAIs) are more likely to have implemented best practices to prevent such infections, according to research presented recently in New Orleans at the annual conference of the Association for Professionals in Infection Control and Epidemiology (APIC).
-
In a discussion that goes well beyond the implied semantics of a simple name change, the Association for Professionals in Infection Control and Epidemiology (APIC) continues to try to define its "brand" in a rapidly changing marketplace.
-
The Centers for Disease Control and Prevention which erred on the side of caution and consternation for infection preventionists during the flu pandemic now concedes surgical masks are sufficient to protect health care workers against H1N1 influenza A. Draft guidelines for seasonal influenza downgrade the controversial recommendation to wear N95 respirators.
-
Data for 64 HIV/HCV co-infected patients treated in a prospective study of pegylated IFN alpha + RBV were analyzed. IFN was administered at 180 mcg SQ/week and RBV was dosed at 800 mg daily for patients with HCV genotype 2 or 3 and 1,000-1,200 mg/day for the first 12 weeks in patients with genotype 1 or 4, then reduced to 800 mg/day until completion of therapy.
-
A prospective, population-based cohort study was conducted from 2002-2006 in the Netherlands of 4,164 children during the first year of life, and included questionnaires and physician-confirmed infections of the upper respiratory tract (URT), lower respiratory tract (LRT), and gastrointestinal tract (GI).
